---
title: "Imbruvica (ibrutinib), all indications: Indication questions"
description: "Indication questions on Imbruvica (ibrutinib) that apply to every indication, each answered with verbatim quotes from the manufacturer's US website for healthcare professionals or documents it links. Topics: Drug names. Questions: When was Imbruvica first approved by the FDA? What is the generic name of Imbruvica? 2 questions quoted from 2 sources."
canonical: "https://www.evicenter.com/medical-information/imbruvica/indication"
published: "2026-11-14T01:54:55-05:00"
modified: "2026-11-14T15:19:23-05:00"
---

# Imbruvica (ibrutinib), all indications: Indication questions

Manufacturer: Pharmacyclics LLC; Janssen Biotech, Inc.  
Prescribing information: [Imbruvica](https://www.rxabbvie.com/pdf/imbruvica_pi.pdf)  
Indication pages: [Chronic lymphocytic leukemia and small lymphocytic lymphoma](https://www.evicenter.com/medical-information/imbruvica--chronic-lymphocytic-leukemia-and-small-lymphocytic-lymphoma)

## Indication

<a id="imbruvica-approval-date"></a>

### When was Imbruvica first approved by the FDA?

> “Initial U.S. Approval: 2013”

Source: [IMBRUVICA: Prescribing information, page 1, captured 2026-11-13](https://www.rxabbvie.com/pdf/imbruvica_pi.pdf#page=1)

> “Approved for over 10 years
> (initial approval 2013)<sup>1</sup>”

Source: [IMBRUVICA: Official Healthcare Professional Website, captured 2026-11-13](https://www.imbruvicahcp.com/#:~:text=Approved%20for%20over%2010%20years,%28initial%20approval)

Note: The year is the first U.S. approval of Imbruvica for any indication.

## Drug names

<a id="imbruvica-generic-name"></a>

### What is the generic name of Imbruvica?

> “IMBRUVICA<sup>®</sup> (ibrutinib) capsules, for oral use 
> IMBRUVICA<sup>®</sup> (ibrutinib) tablets, for oral use 
> IMBRUVICA<sup>®</sup> (ibrutinib) oral suspension”

Source: [IMBRUVICA: Prescribing information, page 1, captured 2026-11-13](https://www.rxabbvie.com/pdf/imbruvica_pi.pdf#page=1)

## Related pages
- [Medical information: Imbruvica (ibrutinib): All indications](https://www.evicenter.com/medical-information/imbruvica)
- [Pharmacology](https://www.evicenter.com/medical-information/imbruvica/pharmacology)
- [Safety](https://www.evicenter.com/medical-information/imbruvica/safety)
- [Specific populations](https://www.evicenter.com/medical-information/imbruvica/specific-populations)
- [Drug interactions](https://www.evicenter.com/medical-information/imbruvica/drug-interactions)
- [Dosing and administration](https://www.evicenter.com/medical-information/imbruvica/dosing-and-administration)
- [Storage and supply](https://www.evicenter.com/medical-information/imbruvica/storage-and-supply)
- [Access and coverage](https://www.evicenter.com/medical-information/imbruvica/access-and-coverage)
